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Mitochondrial carrier homolog 2 (MTCH2) is a re-
pressor of mitochondrial oxidative phosphorylation
(OXPHOS), and its locus is associated with increased
BMI in humans. Here, we demonstrate that mice defi-
cient in muscle MTCH2 are protected from diet-
induced obesity and hyperinsulinemia and that they
demonstrate increased energy expenditure. Deletion
of muscle MTCH2 also increases mitochondrial
OXPHOS and mass, triggers conversion from glyco-
lytic to oxidative fibers, increases capacity for endur-
ance exercise, and increases heart function. More-
over, metabolic profiling of mice deficient in muscle
MTCH2 reveals a preference for carbohydrate utiliza-
tion and an increase in mitochondria and glycolytic
flux in muscles. Thus, MTCH2 is a critical player in
muscle biology, modulating metabolism and mito-
chondria mass as well as impacting whole-body en-
ergy homeostasis.INTRODUCTION
Skeletal muscle is the major body tissue that significantly in-
creases glucose uptake following insulin stimulation. This
behavior underlines the importance of muscle tissue in respond-
ing to carbohydrate availability and is suggested to play an
important role in the development of whole-body insulin resis-
tance and type 2 diabetes accompanied by obesity (Rolfe and
Brown, 1997). The etiologic connection between skeletal muscle
and the metabolic syndrome has been suggested to be partly
due to mitochondrial dysfunction (Lowell and Shulman, 2005;
Mensink et al., 2003; Mootha et al., 2003; Patti et al., 2003).
Based on these observations, it was postulated that increasing
mitochondrial mass/capacity in the skeletal muscle would
potentially restore metabolic balance (Chan and Arany, 2014).
Mitochondrial carrier homolog 2 (MTCH2) is an uncharacter-
ized 33-kDa protein related tomembers of themitochondrial car-1602 Cell Reports 14, 1602–1610, February 23, 2016 ª2016 The Authrier protein family (Grinberg et al., 2005; Monne´ and Palmieri,
2014). Previously, we reported that knocking out MTCH2 in
mice results in embryonic lethality at embryonic day (E)7.5, sug-
gesting that MTCH2 plays a critical role in embryonic develop-
ment (Zaltsman et al., 2010). MTCH2 is a surface-exposed outer
mitochondrial membrane protein that functions as a receptor-
like protein for the BH3-interacting-domain death agonist (BID)
protein and is critical for Fas-induced liver apoptosis (Zaltsman
et al., 2010). More recently, we found that MTCH2 functions as
a repressor of mitochondria metabolism in the hematopoietic
system (Maryanovich et al., 2015). Loss of MTCH2 increases
mitochondrial oxidative phosphorylation (OXPHOS), triggering
the entry of hematopoietic stem cells (HSC) into cycle. Moreover,
elevated OXPHOS is accompanied by an increase in mitochon-
drial size, an increase in ATP and reactive oxygen species (ROS)
levels, and protection from irradiation-induced apoptosis (Mar-
yanovich et al., 2015).
These findings connecting MTCH2 to mitochondrial meta-
bolism regulation relate to many recent genome-wide associa-
tion studies that associate the MTCH2 locus with metabolic dis-
orders, including diabetes and obesity (Fall et al., 2012; Heid
et al., 2010; Hong and Oh, 2012; Leo´n-Mimila et al., 2013; Mei
et al., 2012; van Vliet-Ostaptchouk et al., 2013; Wang et al.,
2012; Willer et al., 2009). These independent studies have
notably identified SNPs that might modify MTCH2 expression/
function/activity. Thus, we were intrigued to find out whether
MTCH2 itself acts as a metabolic regulator and whether its
deregulation might lead to metabolic diseases.
To elucidate the role of MTCH2 in metabolism, we chose to
study the effect of its deletion on muscle function, as well as
on whole-body metabolism.RESULTS
MTCH2F/FMCK-Cre+ Mice Are Protected from
Diet-Induced Obesity and Hyperinsulinemia and
Demonstrate Increased Energy Expenditure
To determine the relevance of the genome-wide association
studies described earlier in an in vivo setting, we generated aors
Figure 1. MTCH2F/FMCK-Cre+ Mice Are Protected from Diet-Induced Obesity and Hyperinsulinemia and Demonstrate Increased Energy
Expenditure
(A) Specific MTCH2 knockout in skeletal muscle and heart. Western blot analysis using anti-MTCH2 antibodies of lysates prepared from skeletal muscle, heart,
and fat tissue of MTCH2F/F (F/F) and MTCH2F/F MCK-Cre+ (Cre) mice. The asterisk marks a crossreactive band. Actin served as a loading control.
(B)MTCH2F/FMCK-Cre+mice gain significantly lessweight on a high-fat diet. Theweight gains of theMTCH2F/F andMTCH2F/FMCK-Cre+ littermatemice fed on a
low-fat diet (LFD; 10% fat) and a high-fat diet (HFD; 45% fat) for 13 weeks are presented. The data represent mean ± SEM. *p% 0.05, two-way ANOVA, n = 12
mice.
(C)MTCH2F/F MCK-Cre+ mice possess less fat on an HFD. Mice, after 13 weeks on an HFD, were analyzed for the weight of their lean and fat tissues using the
EchoMRI device. The data represent mean ± SEM. *p% 0.05, n = 12.
(D) MTCH2F/F MCK-Cre+ mice have reduced levels of plasma insulin after 13 weeks on an HFD. The data represent mean ± SD. *p% 0.05, n = 9 mice.
(E)MTCH2F/FMCK-Cre+mice eatmore on an HFD. Sum of 120 hr food intakemeasuredwhile in themetabolic cages. The data representmean ±SEM. *p% 0.05,
n = 6 mice.
(F) MTCH2F/F MCK-Cre+ mice eat more on a normal chow diet. Sum of 120 hr food intake measured while in the metabolic cages. The data represent
mean ± SEM. *p% 0.05, n = 16 mice.
(G) MTCH2F/F MCK-Cre+ mice gain similar weight as MTCH2F/F mice on a normal chow diet. The weight gains of the MTCH2F/F and MTCH2F/F MCK-Cre+
littermate mice fed on a normal chow diet for 13 weeks are presented. The data represent mean ± SEM. n = 12 mice.
(H)MTCH2F/F MCK-Cre+ mice demonstrate increased energy expenditure. Energy expenditure is expressed as heat production in absolute values (kilocalories
per 24 hr) and statistically controlled for lean body weight. An ANCOVA was performed using a univariate general linear model module in SPSS. *p% 0.05, n = 8
mice.genetic mouse model where MTCH2 deletion is driven by the
muscle creatine kinase (MCK) Cre allele (MTCH2F/FMCK-Cre+)
(Br€uning et al., 1998), resulting in specific MTCH2 knockout
in skeletal muscle and in the heart (Figure 1A; Figure S1A).
The MTCH2F/FMCK-Cre+ mice are viable and fertile and exhibit
no obvious histological abnormalities in the skeletal muscleCell Rtissue (Figure S1B). Metabolic characterization indicates that
MTCH2F/FMCK-Cre+ mice are less susceptible to weight gain,
compared to control mice on a high-fat diet (Figure 1B). Indeed,
MTCH2F/FMCK-Cre+ mice have less fat per body weight (Fig-
ure 1C; Figure S1C) and have lower levels of circulating insulin
(Figure 1D) when fed a high-fat diet. This protection againsteports 14, 1602–1610, February 23, 2016 ª2016 The Authors 1603
weight gain is not due to reduced food intake, as MTCH2F/F
MCK-Cre+ mice eat more than their control littermates on a
high-fat diet (Figure 1E). Also, on a regular chow diet, the
MTCH2F/FMCK-Cre+ mice eat more (Figure 1F) but do not gain
more weight (Figure 1G) and show the same body composition
(Figure S1D). Importantly, theMTCH2F/FMCK-Cre+mice demon-
strate an increase in energy expenditure (Figure 1H; Figure S1E),
suggesting that loss of MTCH2 leads to an increase in whole-
body energy utilization.
Deletion of MTCH2 in Muscle Increases Mitochondrial
OXPHOS and Mass
To characterize MTCH2 deletion impact on muscle morphology
and function, we performed electron microscopy (EM) analyses
on the gastrocnemius muscles (a mixed muscle mostly com-
posed of glycolytic fibers). The analysis revealed a striking in-
crease inmitochondrial area in theMTCH2F/FMCK-Cre+muscles
compared to muscles in the control littermates (Figure 2A).
MTCH2-deficient muscles also showed an increase in mtDNA
(Figure 2B), accompanied by increased expression of the respi-
ratory complexes (Figure 2C).
To define the functional consequence of MTCH2 deletion on
skeletal muscle cell mitochondria, myotubes from MTCH2F/F
mice (Zaltsman et al., 2010) were left untreated or transduced
with purified Cre recombinase (Figure 2D), and cellular respira-
tion was measured. Loss of MTCH2 led to an increase in basal
and maximal oxygen consumption (Figure 2E, left and right
panels) and to an increase in mitochondrial mass (Figure 2F).
We also measured respiration using isolated skeletal muscle
mitochondria and found no differences between the MTCH2F/F
and MTCH2F/FMCK-Cre+ (Figure S2A), suggesting that the
increased respiration in intact cells is likely due to an increase
in mitochondrial mass. As an initial attempt to assess how
lack of MTCH2 leads to an increase in mitochondrial mass,
we assessed the expression levels of the major factors involved
in mitochondrial biogenesis, mitochondrial dynamics, and
autophagy but found no significant differences between the
MTCH2F/F and MTCH2F/F MCK-Cre+ samples (Figures S2B–
S2D, respectively).
Taken together, MTCH2 deletion in skeletal muscle results in a
direct increase in mitochondrial OXPHOS and mass, suggesting
that MTCH2 acts as a repressor of muscle mitochondrial mass/
function.
Deletion of Muscle MTCH2 Triggers Conversion from
Glycolytic to Oxidative Fibers, Increases the Capacity
for Endurance Exercise, and Increases Heart Function
Next, we assessed the effect of increased mitochondrial
mass/function on muscle physiology and started with the
muscle fibers’ type pattern. Consistent with previous studies
(Lin et al., 2002), we found in MTCH2F/FMCK-Cre+ gastrocne-
mius muscle, where mitochondrial OXPHOS content was
elevated, a significant increase in the oxidative myosin heavy
chain 1 (MHC1; type I) fibers and decrease in MHC2b (type
IIB) fibers (Figure 3A, left and right panels). Although the
muscle fiber distribution was changed (from glycolytic to
more oxidative), the basal activity of the MTCH2F/FMCK-Cre+
mice remained similar to that of their wild-type littermates1604 Cell Reports 14, 1602–1610, February 23, 2016 ª2016 The Auth(Figure S3A). However, a forced-endurance exercise test
(with a predetermined ceiling of 425 m) demonstrated
that MTCH2F/FMCK-Cre+ mice performed better than their
MTCH2F/F littermates (Figure 3B) and consumed more oxygen
during this exercise profile (Figure 3C).
MTCH2 protein is as prevalent in heart as in skeletal muscle,
and the MCK-Cre leads to deletion of MTCH2 in both skeletal
and cardiac muscle (Figure 1A). Therefore, next, we performed
an echocardiographic analysis and found that loss of muscle
MTCH2 increases heart function (stroke volume, ejection frac-
tion, and fractional shortening; Figures 3D–3F, respectively),
with no significant change in heart size (Figures S3B–S3D).
Thus, these results suggest that the increase in heart function
is likely to contribute to the improved endurance performance
observed in the MTCH2F/FMCK-Cre+ mice (Figure 3B). We also
used the heart tissue to perform electron microscopy (EM) anal-
ysis (to determine the mitochondrial area) and to measure the
levels of mtDNA, and, in both analyses, we found no significant
differences between the MTCH2F/F and MTCH2F/F MCK-Cre+
samples (Figures S3E and S3F, respectively).
Taken together, MTCH2 deletion in muscle results in an in-
crease in oxidative fibers and in heart function, and both are
likely to contribute to the increases in capacity for endurance
exercise.
Loss of Muscle MTCH2 Leads to Preference for
Carbohydrate Utilization and Increases Mitochondria
and Glycolytic Flux in Muscle
Next, we investigated whether MTCH2 deletion in muscle
would perturb whole-body energy utilization. MTCH2F/FMCK-
Cre+ respiratory exchange ratio (RER) is comparable to that
of control littermates upon basal feeding conditions. Differ-
ences became apparent at the beginning of a fast. While the
control mice showed a significant decrease in RER, as ex-
pected, the MTCH2F/FMCK-Cre+ RER dropped as well, but to
a lesser extent than that of the control mice (Figure 4A). To
further characterize those metabolic changes, we performed
metabolomics and lipidomics profiling of the plasma of the
fed and 24-hr-fasted mice. Interestingly, circulating lactate
levels were elevated in the fed MTCH2F/FMCK-Cre+ mice (Fig-
ure 4B), which was not apparent in the plasma of 24-hr-fasted
MTCH2F/F control mice. Tricarboxylic-acid (TCA)-cycle inter-
mediate levels (fumarate, malate, and a-ketoglutarate) follow
the circulating lactate pattern and are elevated as well in the
MTCH2F/FMCK-Cre+ mice, as compared to those of their con-
trol littermates in the fed state (Figure 4C). These results sug-
gest a higher glycolytic flux and oxidation rate. These metabolic
differences between the two groups disappeared when both
groups were subjected to 24-hr starvation.
Lipidomics analysis revealed some subtle changes. Circu-
lating triacylglycerol (TAG) and diacylglycerol (DAG) levels
dropped upon starvation, as expected in both groups, com-
pared to those in the fed state (Figures S4A and S4B). The circu-
latingMTCH2F/FMCK-Cre+ TAG and DAG levels are similar when
compared to those of theMTCH2F/F control group in both the fed
and starved states. Even though circulating MTCH2F/FMCK-
Cre+ TAGs and DAGs are equivalent to MTCH2F/F TAGs and
DAGs, subtle but significant changes can be observed in specificors
Figure 2. Deletion of MTCH2 in Muscle Increases Mitochondrial OXPHOS and Mass
(A) Loss of MTCH2 leads to an increase in the mitochondrial area in gastrocnemius muscles. Left panels: representative EM images are presented (19003 and
93003 magnifications; scale bars, 5 mm and 500 nm, respectively). Right panel: analysis of mitochondrial area. The data represent mean ± SEM. *p% 0.05.
(B) IncreasedmtDNA abundance inMTCH2F/F MCK-Cre+ gastrocnemiusmuscle. mtDNAwasmeasured by real-time PCR usingChrM andCOX1 (mitochondrial-
encoded genes) expressed relative to HPRT, a housekeeping gene. Glucagon served as the control nuclear-encoded gene. The data represent mean ± SEM.
*p% 0.05, n = 8 mice.
(C) Elevated expression of nuclear- and mitochondrial-encoded mitochondrial respiratory complex subunits in MTCH2F/F MCK-Cre+ gastrocnemius muscle.
Relative gene expression was evaluated by real-time PCR and normalized to HPRT expression. Results are presented as mean relative expression ± SEM. *p%
0.05; **p% 0.01, n = 8 mice.
(D) Representative western blot using anti-MTCH2 antibodies of enriched mitochondrial fractions of myotubes isolated fromMTCH2F/Fmice either left untreated
() or treated (+) with recombinant Cre recombinase. TOM20 serves as a mitochondrial fraction loading control.
(E) Loss of MTCH2 results in increased mitochondrial respiration in myotubes. Left panel: OCRs were measured using the Seahorse XF24 analyzer under basal
conditions and in response to 1.5 mMoligomycin (complex V inhibitor), 4 mMFCCP (uncoupler), or 2 mMRotenone (complex I inhibitor). A representative tracing of
a typical experiment set of four is shown. Right panel: normalized average of results shown in the left panel; Basal andmaximal OCRs (as indicated byOCRbefore
injection of oligomycin and subsequent FCCP). The data represent mean ± SD. **p% 0.01.
(F) Loss of MTCH2 results in an increase in mitochondrial mass. Myotubes were assessed for mitochondria mass usingMito Tracker Green (MTG) as described in
the Supplemental Experimental Procedures. Data are presented as mean ± SEM. *p% 0.05, n = 4.lipids species, such as decreased 16:0-20:4-20:4 and 18:2-18:2-
20:4 (TAGs) and 16:0-20:5 and 18:0-16:0 (DAGs) (Figures S4C
and S4D, respectively). As the MTCH2F/FMCK-Cre+ RER sug-
gested a lower capacity to oxidize fat, we investigated circu-
lating levels of long-chain acylcarnitine (AC) pool. Fasting condi-
tions increased AC content to a similar extent in the MTCH2F/F
and MTCH2F/FMCK-Cre+ groups (Figure S4E), suggesting thatCell RMTCH2-deleted muscle is also capable of utilizing fatty acids
as substrate for oxidation. Thus, MTCH2 muscle-specific
knockout mice maintain fatty acid oxidation capacity but do
exhibit carbohydrate substrate preference, suggesting a role
for MTCH2 in metabolic control.
To determine whether changes in circulating metabolites are
reflecting changes in the muscle metabolites’ pattern uponeports 14, 1602–1610, February 23, 2016 ª2016 The Authors 1605
Figure 3. Deletion of Muscle MTCH2 Triggers Conversion from Glycolytic to Oxidative Fibers, Increases Capacity for Endurance Exercise,
and Increases Heart Function
(A) Loss of MTCH2 triggers conversion from glycolytic to oxidative fibers. Left panels: representative images of immunostaining of MTCH2F/F and MTCH2F/F
MCK-Cre+ gastrocnemiusmuscles. The staining discriminates and reveals the relative abundance ofMHC type I (green), IIA (blue), and IIB (red) fibers. Images are
presented at a 403 magnification; scale bars indicate 20 mm. Right: comparison of muscle fiber type percent distribution between MTCH2F/F and MTCH2F/F
MCK-Cre+ gastrocnemius muscles. The data represent mean ± SEM. *p% 0.05, n = 3 mice.
(B) Loss of MTCH2 increases distance covered by the mice during exercise until exhaustion.MTCH2F/F andMTCH2F/F MCK-Cre+mice underwent an exhaustion
protocol on the treadmill, as described in the Supplemental Experimental Procedures. The data represent mean ± SEM. *p% 0.05, n = 15 mice.
(C) Loss of MTCH2 increases oxygen consumption during the exhaustion profile exercise. The data represent mean ± SEM. *p% 0.05, n = 16 mice; two-way
ANOVA.
(D–F) Loss of MTCH2 increases heart function. Echocardiographic analysis shows an increase in heart function measurements ofMTCH2F/F MCK-Cre+mice, as
compared to MTCH2F/F mice, in stroke volume (D), ejection fraction (E), and fractional shortening (F). The data represent mean ± SEM. *p% 0.05, n = 5 mice.MTCH2 loss, we performed metabolic profiling of the gastrocne-
mius muscles and the soleus muscles (a muscle type mostly
composed of oxidative fibers). The muscles were prepared from
mice either fed or fasted for 24 hr, since it is well established
that fasting increases mitochondrial metabolism (de Lange
et al., 2007). Strikingly, the soleus muscles of the fed MTCH2F/F
MCK-Cre+ mice showed a significant increase in the glycolysis
metabolite pyruvate (Figure 4D) and the TCA-cycle metabolite
malate (Figure 4E), which was similar to the increase in both me-
tabolites in the soleusmuscles of the 24-hr-fastedMTCH2F/F con-
trol mice (Figures 4D and 4E, respectively). Notably, a 24-hr fast of
the MTCH2F/F control mice also increased the levels of fumarate
(TCA cycle) and lactate (glycolysis), and a similar trend was seen
in fed MTCH2F/FMCK-Cre+ mice (Figures 4E and 4F, respec-
tively). The gastrocnemius muscles of the fed MTCH2F/FMCK-
Cre+ mice also showed a similar trend of an increase in glycolysis
and TCA-cycle metabolites (Figures S5A and S5B, respectively).
Simultaneously, glucose uptake is increased inMTCH2F/F-Cre+
primary myotubes (Figure S5C), whileMTCH2F/FMCK-Cre+ mus-
cle glycogen content is also elevated when compared to that in
control muscle (Figure S5D). This suggests that loss of MTCH2
leads to an increase in mitochondria and glycolytic flux but that1606 Cell Reports 14, 1602–1610, February 23, 2016 ª2016 The Auththe excess of carbohydrate is not fully oxidized and stored in
glycogen form. Meanwhile, lower muscle TAGs and DAG levels,
and increased AC (Figures S5E–S5G, respectively), are found
upon starvation in both mouse groups, as expected. However,
there were no significant differences between the muscle
lipid profiles of the MTCH2F/F and MTCH2F/FMCK-Cre+ mice,
mimicking the circulating organic acids’ and lipids’ profile results.
Collectively, we demonstrate that MTCH2 muscle-specific
deletion increases mitochondrial metabolism and mass, which
results in increased muscle metabolic capacity, increased en-
ergy demand and expenditure, and whole-body protection
from diet-induced obesity (Figure 4G).
DISCUSSION
In the present study, we demonstrate that MTCH2 is a critical
player in muscle biology, modulating mitochondrial mass and
its metabolism with a significant impact on whole-body energy
homeostasis.
Many recent genome-wide association studies have associ-
ated the MTCH2 locus with metabolic disorders, including dia-
betes and obesity, suggesting that MTCH2 deregulation mightors
Figure 4. Loss ofMuscleMTCH2 Leads to Preference for Carbohydrate Utilization and IncreasesMitochondria and Glycolytic Flux inMuscle
(A) MTCH2F/F MCK-Cre+ mice maintain a higher RER under fasting conditions. Metabolic cages were used to measure RER during fasting (Food out) and re-
feeding (Food back) in theMTCH2F/F andMTCH2F/F MCK-Cre+mice. The black thick lines at the bottom of the graph represent the 12-hr dark periods. The data
represent mean ± SEM. *p% 0.05, n = 16 mice.
(B and C) Metabolic profiling of plasma prepared from fed and 24-hr-fasted MTCH2F/F and MTCH2F/F MCK-Cre+ mice using LC/MS/MS, showing a significant
increase in lactate (B), and in fumarate andmalate (C), whereas the plasma from 24-hr-fastedMTCH2F/Fmice does not show such an increase. The data represent
mean ± SEM. *p% 0.05; **p% 0.01, n = 5 mice for each treatment.
(D–F) Metabolic profiling of soleus muscles prepared from fed and 24-hr-fasted MTCH2F/F and MTCH2F/F MCK-Cre+ mice using LC/MS/MS. MTCH2F/F MCK-
Cre+muscles prepared from fedmice demonstrate a significant increase in pyruvate (D) andmalate (E), similar to the increase in the 24-hr-fastedMTCH2F/Fmice.
24-hr-fastedMTCH2F/Fmice demonstrated a significant increase in lactate (F), which is not significantly increased in the fedMTCH2F/F MCK-Cre+mice. The data
represent mean ± SEM. *p% 0.05; **p% 0.01, n = 5 mice for each treatment.
(G) Schematic representation of the effect of muscle MTCH2 deletion on mitochondria and muscle metabolism, energy demand and expenditure, and whole-
body protection from diet-induced obesity.lead to metabolic disease. In this study, we indeed found that
MTCH2 deficiency in muscle is beneficial, protecting mice
from a high-fat diet, and that this protection is most likely due
to the increase in mitochondria and muscle metabolism, leading
to elevated whole-body energy demand and elevated energy
expenditure.
Related to these findings are several previous studies that
have postulated that increasing mitochondrial mass in the skel-
etal muscle via expression of PPARg coactivator 1-a (PGC-1a)
would potentially improvemetabolic syndrome (Chan and Arany,Cell R2014). However, muscle-specific overexpression of PGC-1a in
mice did not improve whole-body glucose homeostasis in the
sedentary state; rather, it induced peripheral insulin resistance
on a high-fat diet (Choi et al., 2008). Interestingly, however, as
opposed to the sedentary state, when exercised, the PGC-
1a-muscle transgenic mice reversed this phenotype and dis-
played increased insulin sensitivity (Summermatter et al., 2013).
Importantly, our studies reveal that loss of muscle MTCH2,
which leads to an increase in mitochondrial mass/function, is
sufficient to slow down body weight gain on a high-fat diet andeports 14, 1602–1610, February 23, 2016 ª2016 The Authors 1607
protect from hyperinsulinemia without the requirement of trig-
gered exercise. Moreover, circulating lactate and TCA-cycle in-
termediate levels were elevated in the fed MTCH2F/FMCK-Cre+
mice. Since others have reported that lactate and TCA-cycle
intermediate levels are increased following exercise in humans
(Lewis et al., 2010), it may be speculated that the MTCH2F/F
MCK-Cre+ mice phenocopy an exercised state.
The MTCH2F/FMCK-Cre+ mice eat more on regular chow and
high-fat diets. Simultaneously, loss of MTCH2 increases glucose
uptake and glycogen storage and, under fasting conditions,
maintains carbohydrate metabolism. These results are consis-
tent with the idea that MTCH2F/FMCK-Cre+ mice are in a con-
stant state of increased carbohydrate utilization, but, as the
elevated AC level upon fasting demonstrates, these mice have
retained fatty acid oxidation capacity.
In accordance with the aforementioned findings, the MTCH2-
deficient muscles under fed conditions showed increases in
pyruvate and malate that were similar to the increases seen
in the 24-hr-fasted control muscles. Most likely, the increase in
these metabolites represents an increase in their storage, since
the organism cannot rely on obtaining food from external sources
and shifts to depending solely on its internal sources. Notably, a
24-hr fast of the MTCH2-deficient mice did not further increase
the levels of either glycolysis or TCA-cycle intermediates, sug-
gesting that loss of MTCH2 results in a maximal metabolic
response in themuscles. Thus,MTCH2acts as a critical repressor
of muscle metabolism, and once it is lost, both forms of energy
production—glycolysis and OXPHOS—are upregulated.
As mentioned in the Introduction, we initially characterized
MTCH2 as a receptor-like protein for pro-apoptotic BID (Zalts-
man et al., 2010). Interestingly, several pro-apoptotic proteins
residing at mitochondria—BAD, AIF, and Noxa—have been
recently demonstrated to also play a role in regulating glucose
metabolism (Gime´nez-Cassina et al., 2014; Lowman et al.,
2010; Pospisilik et al., 2007). Notably, muscle- and liver-specific
deletion of AIF improves glucose tolerance and insulin sensitivity
and protects from diet-induced obesity (Pospisilik et al., 2007),
and a BAD phosphomimic variant counteracting unrestrained
gluconeogenesis improves glycemia in leptin-resistant and
high-fat-diet models of diabetes and insulin resistance (Gime´-
nez-Cassina et al., 2014). Thus, the homeostatic crosstalk be-
tween glucosemetabolism and apoptosis seems to be governed
by shared regulatory components (Gime´nez-Cassina andDanial,
2015). In the context of our study, it remains to be determined
whether BID is the upstream metabolic regulator of MTCH2.
In summary, we have identified mitochondrial MTCH2 as a
pivotal regulator of muscle metabolism and whole-body energy
homeostasis. Our findings represent an advance in establishing
the connection betweenmitochondrial function and obesity, with
a potentially important contribution to our understanding of
metabolic diseases in humans.EXPERIMENTAL PROCEDURES
Mice
The Weizmann Institute Animal Care and Use Committee approved all animal
experiments. MTCH2F/F mice were generated as described previously (Zalts-
man et al., 2010). MCK-Cre mice (on a pure C57BL/6 background) were pur-1608 Cell Reports 14, 1602–1610, February 23, 2016 ª2016 The Authchased from Jackson Laboratory (stock #006475). In vivo assays were
repeated in at least three independent experiments with 10- to 14-week-old
littermate male mice. Mice were housed in a reversed-cycle condition of
12 hr/12 hr dark/light, and all experiments were performed in the dark phase
of the day cycle. Mice were fed on a normal chow diet: 17% of kilocalories
from fat and 58% from carbohydrates (total, 3.1 kcal/g).Metabolic Cages
Indirect calorimetry and food intake, as well as locomotor activity, were
measured using the LabMaster system (TSE Systems). The calorimetry system
is an open-circuit system that determines O2 consumption, CO2 production,
and RER. Data were collected after 48 hr of adaptation in acclimated singly
housed mice. Immediately following the measurements of their basal meta-
bolic parameters, mice were deprived of food for 20 hr while in the LabMaster
system. Heat production was adjusted to lean mass using an ANCOVA
(Tscho¨p et al., 2012).High-Fat Diet
Weight-matched experimental littermate mice were fed for 13 weeks with a
high-fat diet (45% of kilocalories from fat, and 35% from carbohydrates; total,
4.7 kcal/g; catalog #D12451, Research Diets) or a low-fat diet (10% of kilocal-
ories from fat and 70% from carbohydrates; total, 3.8 kcal/g; catalog
#D12450B, Research Diets) as a cohort control. Body weights were monitored
every week during the diet. Insulin levels were measured in the serum using an
insulin kit (catalog #90080, Crystal Chem).Metabolic Profiling
Muscles and plasma of fed and 24-hr-fasted mice were assayed for organic
acids at the Sanford Burnham Medical Research Institute (SBMRI) Metabolo-
mics Core. Tissues were lyophilized and subsequently ground into a fine pow-
der using an automated bead-based tissue homogenizer (Precellys Evolution;
Bertin Corporation). Tissues and plasma were assayed for organic acids using
Thermo Quantiva liquid chromatography/tandemmass spectrometry (LC/MS/
MS) instruments, and authentic heavy isotope-labeled internal standards were
used for all organic acids.Muscle Cell Respiration
MTCH2F/F andMTCH2F/F-Cre+myotubes were seeded in XF24 plates (catalog
#100777-004, Seahorse Bioscience). Measurement of intact cellular respira-
tion was performed using the Seahorse XF24 analyzer (Seahorse Bioscience).
Oxygen consumption rates (OCRs) (picomoles of O2 per minute) were
measured under basal conditions and after three consecutive injections of
the following: (1) oligomycin (ATP synthase inhibitor; 1.5 mM); (2) the electron
transport chain accelerator ionophore FCCP (5 mM; FCCP treatment gives
the maximal OCR capacity of the cells); and (3) the electron transport chain in-
hibitor rotenone (2 mM), which stops respiration.Transmission EM
Gastrocnemius muscles and hearts were dissected and placed in relaxation
buffer (Fawcett and McNutt, 1969) for 3 min. Next, samples were fixed with
3% paraformaldehyde, 2% glutaraldehyde in 0.1 M cacodylate buffer contain-
ing 5 mM CaCl2 (pH 7.4). Next, samples were post-fixated in 1% osmium te-
troxide supplemented with 0.5% potassium hexacyanoferrate tryhidrate and
potasssium dichromate in 0.1 M cacodylate (1 hr), stained with 2% uranyl
acetate in water (1 hr), dehydrated in graded ethanol solutions, and embedded
in Agar 100 epoxy resin (Agar Scientific). Ultrathin longitudinal sections
(70–90 nm) were viewed and photographed with a Tecnai Spirit (FEI) transmis-
sion electronmicroscope operated at 120 kV and equipped with an Eagle CCD
(charge-coupled device) camera. Random fields were chosen, and the mito-
chondrial area was measured per total area using ImageJ software.Statistical Analysis
The p values were calculated by using an unpaired Student’s t test.ors
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2016.01.046.
AUTHOR CONTRIBUTIONS
L.B.-A. performed most of the experiments and analyzed all the data pre-
sented in the manuscript. Y.K. was a consultant on the metabolic exper-
iments and performed part of the analysis. M.T. was a consultant on the
behavior experiments. Y.Z. helped in performing part of the experiments,
and L.S. generated the MTCH2F/F mice. S.L.Z. performed the EM studies,
and E.B. performed the echocardiographic analysis. I.M. helped with the
fiber-typing studies, and A.S. helped with the echocardiogram (ECG)
studies. E.T. was a consultant on the heart measurements, M.H was a
consultant in several experiments, and C.V. coordinated the metabolo-
mics and lipidomics profiling and helped in writing the manuscript.
L.B.-A. and A.G. conceived the ideas, planned the projects, and wrote
the manuscript. All authors discussed the results and commented on
the manuscript.
ACKNOWLEDGMENTS
We are grateful to Alon Harmelin, Rebecca Haffner, Alina Maizenberg, Golda
Damari, and Calanit Raanan for help with generating the MTCH2F/F mice.
We also thank Sharon Ovadia, Dalia Vaknin, Nava Nevo, Inbal Biton, and
Yuri Kuznetsov for help with animal studies, and Helena Sabanay for help
with EM studies. This study was supported in part by the Israel Science Foun-
dation (ISF), USA-Israel Binational Science Foundation (BSF), German-Israel
Foundation (GIF), Minerva Stiftung, and a Hyman T. Milgrom Trust grant.
A.G. is the incumbent of the Marketa and Frederick Alexander Professorial
Chair.
Received: August 11, 2015
Revised: December 1, 2015
Accepted: January 13, 2016
Published: February 11, 2016
REFERENCES
Br€uning, J.C., Michael, M.D., Winnay, J.N., Hayashi, T., Ho¨rsch, D., Accili, D.,
Goodyear, L.J., and Kahn, C.R. (1998). A muscle-specific insulin receptor
knockout exhibits features of the metabolic syndrome of NIDDM without
altering glucose tolerance. Mol. Cell 2, 559–569.
Chan, M.C., and Arany, Z. (2014). The many roles of PGC-1a in muscle–recent
developments. Metabolism 63, 441–451.
Choi, C.S., Befroy, D.E., Codella, R., Kim, S., Reznick, R.M., Hwang, Y.-J., Liu,
Z.-X., Lee, H.-Y., Distefano, A., Samuel, V.T., et al. (2008). Paradoxical effects
of increased expression of PGC-1a on muscle mitochondrial function and in-
sulin-stimulated muscle glucose metabolism. Proc. Natl. Acad. Sci. USA 105,
19926–19931.
de Lange, P., Moreno, M., Silvestri, E., Lombardi, A., Goglia, F., and Lanni, A.
(2007). Fuel economy in food-deprived skeletal muscle: signaling pathways
and regulatory mechanisms. FASEB J. 21, 3431–3441.
Fall, T., Arnlo¨v, J., Berne, C., and Ingelsson, E. (2012). The role of obesity-
related genetic loci in insulin sensitivity. Diabet. Med. 29, e62–e66.
Fawcett, D.W., and McNutt, N.S. (1969). The ultrastructure of the cat myocar-
dium. I. Ventricular papillary muscle. J. Cell Biol. 42, 1–45.
Gime´nez-Cassina, A., and Danial, N.N. (2015). Regulation of mitochondrial
nutrient and energy metabolism by BCL-2 family proteins. Trends Endocrinol.
Metab. 26, 165–175.
Gime´nez-Cassina, A., Garcia-Haro, L., Choi, C.S., Osundiji, M.A., Lane, E.A.,
Huang, H., Yildirim, M.A., Szlyk, B., Fisher, J.K., Polak, K., et al. (2014). Regu-Cell Rlation of hepatic energymetabolism and gluconeogenesis by BAD. Cell Metab.
19, 272–284.
Grinberg, M., Schwarz, M., Zaltsman, Y., Eini, T., Niv, H., Pietrokovski, S.,
and Gross, A. (2005). Mitochondrial carrier homolog 2 is a target of tBID in
cells signaled to die by tumor necrosis factor alpha. Mol. Cell. Biol. 25,
4579–4590.
Heid, I.M., Jackson, A.U., Randall, J.C., Winkler, T.W., Qi, L., Steinthorsdottir,
V., Thorleifsson, G., Zillikens, M.C., Speliotes, E.K., Ma¨gi, R., et al.; MAGIC
(2010). Meta-analysis identifies 13 new loci associated with waist-hip ratio
and reveals sexual dimorphism in the genetic basis of fat distribution. Nat.
Genet. 42, 949–960.
Hong, K.W., and Oh, B. (2012). Recapitulation of genome-wide association
studies on body mass index in the Korean population. Int. J. Obes. 36,
1127–1130.
Leo´n-Mimila, P., Villamil-Ramı´rez, H., Villalobos-Compara´n, M., Villarreal-Mo-
lina, T., Romero-Hidalgo, S., Lo´pez-Contreras, B., Gutie´rrez-Vidal, R., Vega-
Badillo, J., Jacobo-Albavera, L., Posadas-Romeros, C., et al. (2013). Contribu-
tion of common genetic variants to obesity and obesity-related traits in
mexican children and adults. PLoS ONE 8, e70640.
Lewis, G.D., Farrell, L., Wood, M.J., Martinovic, M., Arany, Z., Rowe, G.C.,
Souza, A., Cheng, S., McCabe, E.L., Yang, E., et al. (2010). Metabolic signa-
tures of exercise in human plasma. Sci. Transl. Med. 2, 33ra37.
Lin, J., Wu, H., Tarr, P.T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L.F., Puig-
server, P., Isotani, E., Olson, E.N., et al. (2002). Transcriptional co-activator
PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418,
797–801.
Lowell, B.B., and Shulman, G.I. (2005). Mitochondrial dysfunction and type 2
diabetes. Science 307, 384–387.
Lowman, X.H., McDonnell, M.A., Kosloske, A., Odumade, O.A., Jenness, C.,
Karim, C.B., Jemmerson, R., and Kelekar, A. (2010). The proapoptotic function
of Noxa in human leukemia cells is regulated by the kinase Cdk5 and by
glucose. Mol. Cell 40, 823–833.
Maryanovich, M., Zaltsman, Y., Ruggiero, A., Goldman, A., Shachnai, L., Zaid-
man, S.L., Porat, Z., Golan, K., Lapidot, T., and Gross, A. (2015). An MTCH2
pathway repressing mitochondria metabolism regulates haematopoietic
stem cell fate. Nat. Commun. 6, 7901.
Mei, H., Chen, W., Jiang, F., He, J., Srinivasan, S., Smith, E.N., Schork, N.,
Murray, S., and Berenson, G.S. (2012). Longitudinal replication studies of
GWAS risk SNPs influencing body mass index over the course of childhood
and adulthood. PLoS ONE 7, e31470.
Mensink, M., Blaak, E.E., Vidal, H., De Bruin, T.W.A., Glatz, J.F.C., and Saris,
W.H.M. (2003). Lifestyle changes and lipid metabolism gene expression and
protein content in skeletal muscle of subjects with impaired glucose tolerance.
Diabetologia 46, 1082–1089.
Monne´, M., and Palmieri, F. (2014). Antiporters of the mitochondrial carrier
family. Curr. Top. Membr. 73, 289–320.
Mootha, V.K., Lindgren, C.M., Eriksson, K.-F., Subramanian, A., Sihag, S.,
Lehar, J., Puigserver, P., Carlsson, E., Ridderstra˚le, M., Laurila, E., et al.
(2003). PGC-1alpha-responsive genes involved in oxidative phosphoryla-
tion are coordinately downregulated in human diabetes. Nat. Genet. 34,
267–273.
Patti, M.E., Butte, A.J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miya-
zaki, Y., Kohane, I., Costello,M., Saccone, R., et al. (2003). Coordinated reduc-
tion of genes of oxidative metabolism in humans with insulin resistance and
diabetes: Potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. USA 100,
8466–8471.
Pospisilik, J.A., Knauf, C., Joza, N., Benit, P., Orthofer, M., Cani, P.D., Ebers-
berger, I., Nakashima, T., Sarao, R., Neely, G., et al. (2007). Targeted deletion
of AIF decreases mitochondrial oxidative phosphorylation and protects from
obesity and diabetes. Cell 131, 476–491.
Rolfe, D.F., and Brown, G.C. (1997). Cellular energy utilization and molecular
origin of standard metabolic rate in mammals. Physiol. Rev. 77, 731–758.eports 14, 1602–1610, February 23, 2016 ª2016 The Authors 1609
Summermatter, S., Shui, G., Maag, D., Santos, G., Wenk, M.R., and Hand-
schin, C. (2013). PGC-1a improves glucose homeostasis in skeletal muscle
in an activity-dependent manner. Diabetes 62, 85–95.
Tscho¨p, M.H., Speakman, J.R., Arch, J.R., Auwerx, J., Br€uning, J.C., Chan, L.,
Eckel, R.H., Farese, R.V., Jr., Galgani, J.E., Hambly, C., et al. (2012). A guide to
analysis of mouse energy metabolism. Nat. Methods 9, 57–63.
van Vliet-Ostaptchouk, J.V., den Hoed, M., Luan, J., Zhao, J.H., Ong, K.K., van
der Most, P.J., Wong, A., Hardy, R., Kuh, D., van der Klauw,M.M., et al. (2013).
Pleiotropic effects of obesity-susceptibility loci on metabolic traits: a meta-
analysis of up to 37,874 individuals. Diabetologia 56, 2134–2146.
Wang, J., Mei, H., Chen, W., Jiang, Y., Sun, W., Li, F., Fu, Q., and Jiang, F.
(2012). Study of eight GWAS-identified common variants for association with1610 Cell Reports 14, 1602–1610, February 23, 2016 ª2016 The Authobesity-related indices in Chinese children at puberty. Int. J. Obes. 36,
542–547.
Willer, C.J., Speliotes, E.K., Loos, R.J., Li, S., Lindgren, C.M., Heid, I.M.,
Berndt, S.I., Elliott, A.L., Jackson, A.U., Lamina, C., et al.; Wellcome Trust
Case Control Consortium; Genetic Investigation of ANthropometric Traits
Consortium (2009). Six new loci associated with body mass index high-
light a neuronal influence on body weight regulation. Nat. Genet. 41,
25–34.
Zaltsman, Y., Shachnai, L., Yivgi-Ohana, N., Schwarz, M., Maryanovich, M.,
Houtkooper, R.H., Vaz, F.M., De Leonardis, F., Fiermonte, G., Palmieri, F.,
et al. (2010). MTCH2/MIMP is a major facilitator of tBID recruitment to mito-
chondria. Nat. Cell Biol. 12, 553–562.ors
